Shanghai Haohai Biological Technology Co., Ltd. (688366.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 28.84

From 52W high−14.06%

Volume484378.00

Market capCNY 6.74B

P/E (TTM)26.9x

P/S (TTM)2.7x

Div yield4.33%

Key dataSep 18, 2026

Open

CNY 28.84

From 52W high

−14.06%

Volume

484378.00

Market cap

CNY 6.74B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.7x

P/E (TTM)

26.9x

RSI (14)

36.8

MomentumView details →

1D Return

−6.21%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

26.9x

EV/EBITDA

11.7x

EV/Sales

2.0x

P/S (TTM)

2.7x

P/B (TTM)

1.3x

ProfitabilityView details →

Gross Margin

69.38%

Net Margin

9.66%

EBITDA Margin

16.63%

ROE (TTM)

4.30%

ROA (TTM)

3.51%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

−9.15%

EPS YoY

−42.95%

FCF YoY

−53.60%

Revenue CAGR 3Y

+5.10%

EPS CAGR 3Y

+1.27%

EBITDA YoY

—

MomentumView details →

1D Return

−6.21%

YTD Return

—

1Y Return

—

RSI (14)

36.8

vs 50D SMA

−6.89%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

3.73x

Quick Ratio

3.14x

Div Yield

4.33%

Div Rate

CNY 1.25

Div Growth 1Y

−15.00%

EarningsView details →

EPS (Actual)

CNY 0.17

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.35B

Net Income (TTM)

152.41M

Op. CF (TTM)

336.39M

Next earningsOct 23, 2026 →

Latest newsMore news →

Shanghai Haohai Biological Technology Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 113 million yuan, down 46.64% year-on-year.30d ago

Shanghai Haohai Biological Technology Co., Ltd. announced a cash dividend of 2.5 yuan per 10 shares (tax inclusive), totaling 56.1875 million yuan (tax inclusive).30d ago

Similar companies

Arcellx, Inc.ACLX Rhythm Pharmaceuticals, Inc.RYTM 艾迪药业688488.SH CG Oncology, Inc. Common stockCGON Belite Bio, IncBLTE 奥翔药业603229.SH Find similar companies →

Latest newsMore news →

Shanghai Haohai Biological Technology Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 113 million yuan, down 46.64% year-on-year.30d ago Shanghai Haohai Biological Technology Co., Ltd. announced a cash dividend of 2.5 yuan per 10 shares (tax inclusive), totaling 56.1875 million yuan (tax inclusive).30d ago